Webinars

Tutors

• Dr Helen Toal
  Consultant Psychiatrist in Addictions
• Mr Clifford McElhinney
  
• Mrs Joanne Crawford
  Pharmacy Adviser, HSCB

Aim

To enable pharmacists to effectively contribute to the shared care team delivering substitution therapy services in Northern Ireland.

Learning outcomes

Having completed this workshop you will be able to:

• discuss the Northern Ireland Guidelines on substitution treatments for opioid dependence
• describe the pharmacological properties of methadone and buprenorphine
• understand the rationale for initiating treatment and thereafter the stabilisation of treatment
• supervise consumption in individuals appropriately
• understand other harm reduction services available from community pharmacy
• appreciate the role of all professionals involved in the shared care of service users.

Tutors

• Mr Christopher Garland
  
• Mr Matthew Dolan
  Public Health Pharmacist, HSCB.
• Dr Brenda Bradley
  Pharmacy Lead - Medicines Governance and Public Health.
• Ms Angela Carrington
  

Aim

To improve the safe use of medicines through the implementation of the medication safety campaign, “Know, Check, Ask”, aligning with the WHO Third global patient safety challenge ‘Medication without harm’.

Learning outcomes

Having completed this webinar you will be able to:

• Increase public awareness of the WHO Third global patient safety challenge ‘Medication without harm’
• Outline the Northern Ireland response to the WHO Challenge ‘Medication without harm’
• Implement the values of the ‘Know, Check, Ask’ medication safety campaign into your professional practice
• Utilise tools and resources to support the ‘Know, Check, Ask’ campaign.

Tutors

• Mr Christopher Garland
  
• Mr Matthew Dolan
  Public Health Pharmacist, HSCB.
• Dr Brenda Bradley
  Pharmacy Lead - Medicines Governance and Public Health.
• Ms Angela Carrington
  

Aim

To improve the safe use of medicines through the implementation of the medication safety campaign, “Know, Check, Ask”, aligning with the WHO Third global patient safety challenge ‘Medication without harm’.

Learning outcomes

Having completed this webinar you will be able to:

• Increase public awareness of the WHO Third global patient safety challenge ‘Medication without harm’
• Outline the Northern Ireland response to the WHO Challenge ‘Medication without harm’
• Implement the values of the ‘Know, Check, Ask’ medication safety campaign into your professional practice
• Utilise tools and resources to support the ‘Know, Check, Ask’ campaign.

Tutors

• Mr Christopher Garland
  
• Mr Matthew Dolan
  Public Health Pharmacist, HSCB.
• Dr Brenda Bradley
  Pharmacy Lead - Medicines Governance and Public Health.
• Ms Angela Carrington
  

Aim

To improve the safe use of medicines through the implementation of the medication safety campaign, “Know, Check, Ask”, aligning with the WHO Third global patient safety challenge ‘Medication without harm’.

Learning outcomes

Having completed this webinar you will be able to:

• Increase public awareness of the WHO Third global patient safety challenge ‘Medication without harm’
• Outline the Northern Ireland response to the WHO Challenge ‘Medication without harm’
• Implement the values of the ‘Know, Check, Ask’ medication safety campaign into your professional practice
• Utilise tools and resources to support the ‘Know, Check, Ask’ campaign.

Tutors

• Mrs Maire McGrady
  Regional Lead Cancer Services Pharmacist (job share), BHSCT.
• Dr Ian Sturgess
  Oncology/Haematology Pharmacist, BHSCT.

Aim

To provide pharmacists with a general overview of the use of supportive medicines in cancer and to identify how pharmacists can support people living with cancer.

Learning outcomes

Having completed these two workshops you should be able to:

• Appreciate the range of medicines used in the treatment of cancer
• Highlight the general side-effects associated with systemic anti-cancer therapy (SACT) and radiotherapy
• Define the role of supportive medicines in cancer therapy
• Recognise the range of supportive medication prescribed in cancer patients and their appropriateness for particular patient groups
• Provide appropriate support and advice regarding supportive medicines to people receiving treatment for cancer.